Prognostic Significance of Postoperative Morbidities in Patients With Advanced Epithelial Ovarian Cancer Treated With Neoadjuvant Chemotherapy and Delayed Primary Surgical Debulking

被引：0
|
作者：
Tien Le
Ghadeer Alshaikh
Laura Hopkins
Wylam Faught
Michael Fung Kee Fung
机构：
[1] Ottawa General Hospital,Division of Gynecologic Oncology
[2] 205-CSC Royal Alexandra Hospital,Division of Gynecologic Oncology
来源：
Annals of Surgical Oncology | 2006年 / 13卷
关键词：
Postoperative morbidities; Neoadjuvant chemotherapy; Prognosis; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1711 / 1716
页数：5
相关论文
共 50 条
  • [1] Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking
    Le, Tien
    Alshaikh, Ghadeer
    Hopkins, Laura
    Faught, Wylam
    Fung, Michael Kee Fung
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (12) : 1711 - 1716
  • [2] Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking
    Le, T.
    Williams, K.
    Senterman, M.
    Hopkins, L.
    Faught, W.
    Fung-Kee-Fung, M.
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 160 - 163
  • [3] Omental chemotherapy effects as a prognostic factor in ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking
    Le, Tien
    Williams, Kona
    Senterman, Mary
    Hopkins, Laura
    Faught, Wylam
    Fung-Kee-Fung, M.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (09) : 2649 - 2653
  • [4] Omental Chemotherapy Effects as a Prognostic Factor in Ovarian Cancer Patients Treated With Neoadjuvant Chemotherapy and Delayed Primary Surgical Debulking
    Tien Le
    Kona Williams
    Mary Senterman
    Laura Hopkins
    Wylam Faught
    M. Fung-Kee-Fung
    Annals of Surgical Oncology, 2007, 14 : 2649 - 2653
  • [5] The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking
    Le, T.
    Hopkins, L.
    Faught, W.
    Fung-Kee-Fung, M.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (03) : 712 - 715
  • [6] Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking
    Le, T.
    Shahriari, P.
    Hopkins, L.
    Faught, W.
    Fung, M. Fung Kee
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 986 - 990
  • [7] The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery
    Shi-Ping Yang
    Jian-Xian Chen
    Jing-Ying Xu
    Lei, Jian
    San-Gang Wu
    Zhou, Juan
    CANCER MEDICINE, 2022, 11 (14): : 2836 - 2845
  • [8] PRIMARY DEBULKING SURGERY OR NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER?
    Mansouri, H.
    Zemni, I.
    Ben Safta, I.
    Achouri, L.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A120 - A120
  • [9] Predictive Factors for Surgical Morbidities and Adjuvant Chemotherapy Delay for Advanced Ovarian Cancer Patients Treated by Primary Debulking Surgery or Interval Debulking Surgery
    Ruiz Castro, Beatriz Guerreiro
    dos Reis, Ricardo
    Cintra, Georgia Fontes
    de Assuncao Sousa, Mileide Maria
    Vieira, Marcelo de Andrade
    Mattos da Cunha Andrade, Carlos Eduardo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (08) : 1520 - 1528
  • [10] Readmissions among advanced ovarian cancer patients treated with neoadjuvant chemotherapy as compared to primary debulking surgery
    Gonzalez, R.
    Gockley, A. A.
    Hicks-Courant, K.
    Fiascone, S.
    del Carmen, M. G.
    Clark, R. M.
    Berkowitz, R. S.
    Muto, M. G.
    Horowitz, N. S.
    Worley, M. J., Jr.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 230 - 230
12345